The FDA has previously informed
“The feedback from FDA is an important step in the process to DiviTum®TKa’s 510(k) clearance. As soon as normal activities are resumed, the FDA can begin the review,” said
© Modular Finance, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.14 SEK | +3.88% | -10.83% | -17.05% |
Apr. 13 | Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. | CI |
Apr. 12 | Biovica International AB Announces Divitum® Tka in Observational Trial | CI |
The FDA has previously informed
“The feedback from FDA is an important step in the process to DiviTum®TKa’s 510(k) clearance. As soon as normal activities are resumed, the FDA can begin the review,” said
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-17.05% | 15.86M | |
-15.64% | 11.33B | |
+39.24% | 3.16B | |
-18.79% | 2.04B | |
-34.97% | 2.14B | |
-27.84% | 1.49B | |
+12.52% | 975M | |
-4.37% | 731M | |
-48.78% | 364M | |
+26.64% | 371M |